Trials / Conditions / Stage IV Merkel Cell Carcinoma AJCC v7
Stage IV Merkel Cell Carcinoma AJCC v7
3 registered clinical trials studyying Stage IV Merkel Cell Carcinoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immu NCT02584829 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer NCT02267603 | National Cancer Institute (NCI) | Phase 2 |